Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled PPP001 Versus Immediate-release Oral Opioids for the Management of Breakthrough Pain in Cancer Subjects: a Randomized, Open Label, Crossover, Comparison Study

NCT03564548 is registered in ClinicalTrials.gov with Tetra Bio-Pharma as lead sponsor.

NCT NCT03564548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03564548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled PPP001 Versus Immediate-release Oral Opioids for the Management of Breakthrough Pain in Cancer Subjects: a Randomized, Open Label, Crossover, Comparison Study
Lead sponsor
Tetra Bio-Pharma
Phase
Phase 2
Overall status
Unknown status
Start date
May 26, 2021
Completion date
April 30, 2022
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breakthrough cancer pain, cancer